Skip to main content
. 2024 Jan 12;23(1):139–149. doi: 10.1002/wps.21183

Table 2.

Subgroup analyses on all available trials

Depressive symptoms Generalized anxiety symptoms
Analysis n g (95% CI) I2 NNT p n g (95% CI) I2 NNT p
Control group 0.003 0.216
Inactive 112 0.33 (0.27‐0.39) 68% 9.5 96 0.28 (0.23‐0.33) 48% 11.4
Placebo 49 0.19 (0.11‐0.27) 70% 17.4 38 0.19 (0.11‐0.28) 55% 17.4
Care as usual 20 0.18 (0.07‐0.27) 49% 18.4 16 0.32 (0.09‐0.54) 88% 9.2
Sample <0.001 0.080
Pre‐selected 45 0.52 (0.38‐0.65) 88% 5.2 32 0.35 (0.23‐0.46) 62% 8.9
Unselected 136 0.21 (0.17‐0.26) 56% 15.6 118 0.24 (0.18‐0.29) 64% 13.5
Psychiatric diagnosis 0.669 0.068
Yes 14 0.23 (0.05‐0.40) 60% 14.2 10 0.41 (0.24‐0.58) 35% 7.5
No 167 0.28 (0.23‐0.33) 73% 11.4 140 0.25 (0.20‐0.30) 65% 12.9
CBT app 0.003 0.147
Yes 86 0.35 (0.28‐0.42) 79% 8.9 59 0.30 (0.24‐0.36) 46% 10.6
No 95 0.21 (0.15‐0.27) 59% 15.6 91 0.23 (0.16‐0.30) 69% 14.2
Mindfulness app 0.549 0.258
Yes 43 0.26 (0.19‐0.33) 45% 12.4 45 0.23 (0.15‐0.30) 46% 14.2
No 138 0.29 (0.23‐0.34) 75% 11.0 105 0.28 (0.22‐0.35) 68% 11.4
Cognitive training app 0.238 0.370
Yes 21 0.18 (0.02‐0.35) 66% 18.4 18 0.20 (0.07‐0.33) 39% 16.5
No 160 0.29 (0.24‐0.34) 73% 11.0 132 0.26 (0.21‐0.31) 65% 12.4
Mood monitoring features 0.257 0.369
Yes 65 0.24 (0.19‐0.30) 44% 13.5 51 0.23 (0.17‐0.29) 33% 14.2
No/Not reported 116 0.29 (0.23‐0.36) 78% 11.0 99 0.27 (0.20‐0.34) 71% 11.9
Chatbot feature 0.009 0.258
Yes 12 0.53 (0.33‐0.74) 61% 5.6 10 0.18 (0.06‐0.31) 0% 18.4
No/Not reported 169 0.26 (0.21‐0.31) 72% 12.4 140 0.26 (0.21‐0.32) 66% 12.4
Human guidance offered 0.936 0.477
Yes 27 0.29 (0.13‐0.46) 65% 11.0 18 0.37 (0.03‐0.71) 88% 8.4
No/Not reported 154 0.28 (0.23‐0.32) 73% 11.4 132 0.24 (0.20‐0.29) 52% 13.5

n – number of comparisons, NNT – number needed to treat, CBT – cognitive behavioral therapy